| Literature DB >> 33846043 |
Sophia Hatziantoniou1, Helena C Maltezou2, Athanasios Tsakris3, Gregory A Poland4, Cleo Anastassopoulou5.
Abstract
Entities:
Keywords: Allergy; Anaphylaxis; BNT162b2; COVID-19; Excipients; Hypersensitivity; Lipid nanoparticles (LNPs); Polyethylene glycol (PEG); SARS-CoV-2; Spike
Year: 2021 PMID: 33846043 DOI: 10.1016/j.vaccine.2021.03.073
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641